Worth reading
—
Scored from 0 of 4 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
9.2
Year-on-year increase in sales revenue (%)Wording
Definitive
How definitive the wording is.Resolutions for the General Meeting of Shareholders
Annual (111th term)Shareholder Proposal
None stated (this document comprises other matters subject to electronic provision and contains no proposals)
A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.| Item | Details |
|---|---|
| Type of shareholders' meeting | Annual (111th term) |
| Shareholder Proposal | None stated (this document comprises other matters subject to electronic provision and contains no proposals) |
Items this document does not state (4)
Date and timeMatters for resolutionDirector nomineePercentage voting in favor
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Global medical demand continued to expand, and the core businesses grew overseas, particularly in the Americas. Operating profit increased because the Company implemented profitability improvement measures centered on product price increases and improved production efficiency.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.